Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senegal loses $7m malaria grant:

This article was originally published in Clinica

Executive Summary

The Global Fund to fight AIDS, Malaria and Tuberculosis has withdrawn Senegal's $7.1m five-year grant to tackle malaria. Citing "systemic issues that resulted in poor performance" against initial two-year targets, the decision constitutes the Global Fund's first formal discontinuation and is encouraging the country to re-apply. Senegal was part of the first ever round of phase 1 evaluations conducted by the Global Fund. Another 21, with a value of $119m, were approved for a second three-year phase; three grants remain under review. The Global Fund currently has $3.1bn in phase-1 grants in 127 countries.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT054499

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel